- Trials with a EudraCT protocol (1,074)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (188)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: EVALUATION OF THE CUMMULATIVE IRRITANCY POTENIAL OF DIFFERIN GEL, 0.1% AND DIFFERIN SOLUTION, 0.1% COMPARED TO AVITA CREAM, 0.025%, AVITA GEL, 0.025%, TAZORAC GEL, 0.1%, TAZORAC GEL, 0.05%, AND RETIN-Z MICRO, 0.1% FOLLOWING REPEATED APPLICATIONS TO THE SKIN OF HUMANS - PHASE I/IV |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46266 |
| Study title: SAFETY AND EFFICACY COMPARISON OF DIFFERIN (ADAPALENE GEL) GEL, 0.1 % VERSUS RETIN-A CREAM, 0.05 % IN SUBJECTS WITH ACNE VULGARIS – PHASE IV |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46258 |
| Study title: US - BILATERAL (HALF-FACE) TOLERANCE COMPARISON OF DIFFERIN TM (ADAPALENE GEL) GEL, 0.1% VERSUS RETIN-A CREAM, 0.025% IN SUBJECTS WITH ACNE VULGARIS – PHASE IV |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46256 |
| Study title: US - BILATERAL (HALF-FACE) TOLERANCE COMPARISON OF DIFFERIN TM (ADAPALENE GEL) GEL, 0.1 % VERSUS RETIN-A CREAM, 0.025% IN SUBJECTS WITH ACNE VULGARIS – PHASE IV |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46255 |
| Study title: US - BILATERAL (HALF-FACE) TOLERANCE COMPARISON OF DIFFERIN TM (ADAPALENE GEL), 0.1% VERSUS RETIN-A CREAM, 0.025% IN SUBJECTS WITH ACNE VULGARIS – COMBINED RESULTS FROM STUDIES CR.U9606 AND CR.U9607 |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46257 |
| Study title: US - BILATERAL FACIAL TOLERANCE COMPARISON OF DIFFERIN TM (ADAPALENE GEL) GEL, 0.1% AND RETIN-A , 0.025% AND 0.05% CREAMS |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46252 |
| Study title: US - PHARMACOKINETIC EVALUATION OF DIFFERIN (ADAPALENE CREAM) CREAM, 0.1% FOLLOWING MAXIMAL EXPOSURE WITH MULTIPLE APPLICATIONS IN SUBJECTS WITH ACNE VULGARIS - PHASE I |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46250 |
| Study title: US - SAFETY AND EFFICACY COMPARISON OF DIFFERIN (ADAPALENE CREAM) CREAM, 0.1% AND DIFFERIN (ADAPALENE CREAM) CREAM VEHICLE IN THE TREATMENT OF ACNE VULGARIS - PHASE III |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46251 |
| Study title: The treatment of acne vulgaris with graded abrasive creams. |
| Active substance: ALUMINIUM OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46487 |
| Study title: LOCERYL - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF VARIOUS CONCENTRATIONS OF AMOROLFINE (Ro 14-4767, LOCERYL) CREAM APPLIED ONCE DAILY TO PATIENTS WITH TINEA PEDIS |
| Active substance: AMOROLFINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21705 |
| Study title: Open-Label Evaluation of 5% 5. Benzoyl Peroxide/1% Clindamycin Gel used in combination with Tazarotene 0.1% Cream and Oral Minocycline in the treatment of severe acne vulgaris. |
| Active substance: BENZOYLPEROXIDE AND CLINDAMYCIN |
| Study summary document link (including results): Article 45_Ref_U0515_Final for Submission_09Nov2011.xlsx |
| View full study record |
| Document reference: 22329 |
| Study title: A phase IV Multi-Center, Open-label Safety Study in pediatric Patients with atopic dermatitis, Treated with Diprolen AF Cream 0,05 % Twice daily, or diprosone ointment |
| Active substance: BETAMETHASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41911 |
| Study title: Study of 0.01% betamethasone cream vs. placebo in steroid-sensitive dermatoses in children (1 to 12 years) – An incomplete, aborted study. Research Report 932-0460. |
| Active substance: BETAMETHASONE |
| Study summary document link (including results): betamethasone RR932-0460.pdf |
| View full study record |
| Document reference: 47778 |
| Study title: Study of 0.1% betamethasone cream vs placebo in steroid sensitive dermatoses in children (1 to 12 years) - an incomplete, aborted study. |
| Active substance: BETAMETHASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41912 |
| Study title: Fucicort fatty cream in clinically infected atopic dermatitis |
| Active substance: BETAMETHASONE AND FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45094 |
| Study title: Fucicort fatty cream in clinically infected atopic dermatitis |
| Active substance: BETAMETHASONE AND FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41919 |
| Study title: Efficacy and tolerability of bifonazole cream 1% and solution 1% in dermatomycosis. |
| Active substance: BIFONAZOLE |
| Study summary document link (including results): Bifonazole_0399.pdf |
| View full study record |
| Document reference: 47218 |
| Study title: Efficacy and tolerability of bifonazole cream 1% and solution 1% in dermatomycosis |
| Active substance: BIFONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22411 |
| Study title: Efficacy and tolerability of bifonazole cream 1% and solution 1% in dermatomycosis |
| Active substance: BIFONAZOLE |
| Study summary document link (including results): Bayer CC_Bifonazole_0340_study_synopsis.pdf |
| View full study record |
| Document reference: 22417 |
| Study title: A multi-centre, open, non-comparative study of the efficacy and irritation potential of 4% benzoyl peroxide cream in hydrophase base (Brevoxyl) in treatment of mild to moderate acne vulgaris. |
| Active substance: BENZOYL PEROXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22321 |
